Venetoclax for Chronic Lymphocytic Leukaemia Progressing after Ibrutinib: a Multicentre, Open-Label...
Venetoclax for Chronic Lymphocytic Leukaemia Progressing after Ibrutinib: a Multicentre, Open-Label Phase 2 Trial
About this item
Full title
Author / Creator
Jones, Jeffrey A. , Mato, Anthony R. , Wierda, William G. , Davids, Matthew S. , Choi, Michael , Cheson, Bruce D. , Furman, Richard R. , Lamanna, Nicole , Barr, Paul M. , Zhou, Lang , Chyla, Brenda , Salem, Ahmed Hamed , Verdugo, Maria , Humerickhouse, Rod A. , Potluri, Jalaja , Coutre, Steven , Woyach, Jennifer and Byrd, John C.
Journal title
Language
English
Formats
More information
Alternative Titles
Full title
Venetoclax for Chronic Lymphocytic Leukaemia Progressing after Ibrutinib: a Multicentre, Open-Label Phase 2 Trial
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6027999
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6027999
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(17)30909-9
